These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10403908)
21. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors. Fujii Y; Okumura M; Yamamoto S J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845 [TBL] [Abstract][Full Text] [Related]
22. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. Gilhus NE; Willcox N; Harcourt G; Nagvekar N; Beeson D; Vincent A; Newsom-Davis J J Neuroimmunol; 1995 Jan; 56(1):65-76. PubMed ID: 7822483 [TBL] [Abstract][Full Text] [Related]
23. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy. Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743 [TBL] [Abstract][Full Text] [Related]
24. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072 [TBL] [Abstract][Full Text] [Related]
25. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Abril E; Mendez RE; García A; Serrano A; Cabrera T; Garrido F; Ruiz-Cabello F Tissue Antigens; 1996 May; 47(5):391-8. PubMed ID: 8795139 [TBL] [Abstract][Full Text] [Related]
26. Delta-T-lymphocytosis in a patient with thymoma. Lishner M; Ravid M; Shapira J; Radnay J; Amiel A; Leytin V; Shapiro C; Klein A Cancer; 1994 Dec; 74(11):2924-9. PubMed ID: 7525037 [TBL] [Abstract][Full Text] [Related]
27. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma. Fujii Y; Hayakawa M; Nakahara K J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308 [TBL] [Abstract][Full Text] [Related]
28. The modulation of class I and class II MHC molecules on intestinal epithelial cells at different stages of differentiation. Donnet-Hughes A; Borel Y; Schiffrin EJ Adv Exp Med Biol; 1995; 371A():247-9. PubMed ID: 8525918 [No Abstract] [Full Text] [Related]
29. Mature CD4 single positive thymocytes in human Thymoma: T cells may differentiate in the thymic epithelial cell tumor. Inoue M; Fujii Y; Okumura M; Takeuchi Y; Shiono H; Miyoshi S; Matsuda H; Shirakura R Pathobiology; 1997; 65(4):216-22. PubMed ID: 9396046 [TBL] [Abstract][Full Text] [Related]
30. T-cell lymphocytosis associated with lymphocyte-rich thymoma. Barton AD Cancer; 1997 Oct; 80(8):1409-17. PubMed ID: 9338464 [TBL] [Abstract][Full Text] [Related]
31. Immaturity of lymphocytes in the metastatic lesions of thymoma. Inoue M; Okumura M; Fujii Y; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H Clin Immunol Immunopathol; 1998 Sep; 88(3):249-55. PubMed ID: 9743611 [TBL] [Abstract][Full Text] [Related]
32. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells. Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946 [TBL] [Abstract][Full Text] [Related]
33. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related]
34. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis. Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972 [TBL] [Abstract][Full Text] [Related]
36. Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism. Smith CI; Borgonovo L; Carlsson B; Hammarström L; Rabbitts TH Ann N Y Acad Sci; 1987; 505():388-97. PubMed ID: 3120635 [No Abstract] [Full Text] [Related]
37. [Histological studies of thymomas from 17 myasthenia gravis and 1 pure red cell aplasia patients and the T cell subsets before and after in vitro culture with rIL-2]. Takiguchi T Arerugi; 1993 May; 42(5):665-75. PubMed ID: 8323466 [TBL] [Abstract][Full Text] [Related]
38. Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis. Medeiros LJ; Bhagat SK; Naylor P; Fowler D; Jaffe ES; Stetler-Stevenson M Arch Pathol Lab Med; 1993 Mar; 117(3):279-83. PubMed ID: 8382915 [TBL] [Abstract][Full Text] [Related]
39. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312 [TBL] [Abstract][Full Text] [Related]
40. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]